Cargando…
Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978496/ https://www.ncbi.nlm.nih.gov/pubmed/31582343 http://dx.doi.org/10.1016/j.htct.2018.11.004 |
| _version_ | 1783490714259161088 |
|---|---|
| author | Silva, Wellington Fernandes da Marquez, Gabriel Lacerda Salim, Rafael Calil Rocha, Vanderson |
| author_facet | Silva, Wellington Fernandes da Marquez, Gabriel Lacerda Salim, Rafael Calil Rocha, Vanderson |
| author_sort | Silva, Wellington Fernandes da |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6978496 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Sociedade Brasileira de Hematologia e Hemoterapia |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69784962020-01-28 Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin Silva, Wellington Fernandes da Marquez, Gabriel Lacerda Salim, Rafael Calil Rocha, Vanderson Hematol Transfus Cell Ther Case Report Sociedade Brasileira de Hematologia e Hemoterapia 2019 2019-03-21 /pmc/articles/PMC6978496/ /pubmed/31582343 http://dx.doi.org/10.1016/j.htct.2018.11.004 Text en © 2019 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Case Report Silva, Wellington Fernandes da Marquez, Gabriel Lacerda Salim, Rafael Calil Rocha, Vanderson Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin |
| title | Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin |
| title_full | Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin |
| title_fullStr | Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin |
| title_full_unstemmed | Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin |
| title_short | Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin |
| title_sort | primary refractory b-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978496/ https://www.ncbi.nlm.nih.gov/pubmed/31582343 http://dx.doi.org/10.1016/j.htct.2018.11.004 |
| work_keys_str_mv | AT silvawellingtonfernandesda primaryrefractorybcelllymphoblasticleukemiawithextramedullarydiseaseadistinctiveresponsetoblinatumomabandinotuzumabozogamicin AT marquezgabriellacerda primaryrefractorybcelllymphoblasticleukemiawithextramedullarydiseaseadistinctiveresponsetoblinatumomabandinotuzumabozogamicin AT salimrafaelcalil primaryrefractorybcelllymphoblasticleukemiawithextramedullarydiseaseadistinctiveresponsetoblinatumomabandinotuzumabozogamicin AT rochavanderson primaryrefractorybcelllymphoblasticleukemiawithextramedullarydiseaseadistinctiveresponsetoblinatumomabandinotuzumabozogamicin |